Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service decompression & minimally invasive spine cases in New York: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 4% on average (250 state-years, 2020–2024): a close guide.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 127 | 5,804 | 46% |
| 2020 | 95 | 4,240 | 48% |
| 2021 | 104 |
Laminotomy, laminectomy, interspinous devices; the MIS call point. Professional codes (what the surgeon bills): CPT 63030, 63047, 63020, 63045, 22867; the hospital bills MS-DRG 518, 519, 520.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 23% of the cases CMS names in New York; 73 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Pennsylvania | 95 | 4,474−6.6%/yr | −6.6%/yr | 3.2 | 2% | 4,650 in 2030+0.6%/yr |
| Massachusetts | 67 |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Lumbar fusion | 96 | 3,407−0.3%/yr | −0.3%/yr | 1.80.8× | 1% | 4,050 in 2030+2.9%/yr |
| Cervical fusion & disc arthroplasty |
Decompression & minimally invasive spine in every state, and its device makers · Every procedure market in New York · Every state · Compare with Pennsylvania
| 2024 |
| 4,671 |
| 57% |
| 2025 est. | ≈ 4,590 | – |
| 2026 est. | ≈ 4,630 | – |
| 4,705 |
| 51% |
| 2022 | 111 | 4,640 | 53% |
| 2023 | 107 | 4,627 | 55% |
| 2024 | 113 | 4,671 | 57% |
| 2025 from claims | – | 4,591 4,213–4,857 | 58% |
| 2026 forecast | – | 4,634 4,077–5,347 | 58% |
| 2027 forecast | – | 4,657 3,981–5,550 | 59% |
| 2028 forecast | – | 4,680 3,905–5,731 | 59% |
| 2029 forecast | – | 4,703 3,841–5,897 | 60% |
| 2030 forecast | – | 4,724 3,785–6,054 | 60% |
In 2025, 67% inpatient hospital, 30% hospital outpatient, 3% surgery center. The share outside the hospital has moved +3 pts since 2019, so more of this market is decided in surgery centers and offices each year.
| 2,826−4.4%/yr |
| −4.4%/yr |
| 2.9 |
| 0% |
| 3,400 in 2030+3.1%/yr |
| New Jersey | 62 | 2,530−1.6%/yr | −1.6%/yr | 2.3 | 4% | 2,680 in 2030+1%/yr |
| Connecticut | 25 | 1,006−5.7%/yr | −5.7%/yr | 2.9 | 5% | 1,000 in 2030−0.1%/yr |
| New Hampshire | 13 | 531−10%/yr | −10%/yr | 2.3 | 19% | 900 in 2030+9.2%/yr |
| Rhode Island | 10 | 326−4.7%/yr | −4.7%/yr | 3.4 | 0% | 340 in 2030+0.7%/yr |
| Maine | 7 | 255−15%/yr | −15%/yr | 1.6 | 0% | 290 in 2030+2%/yr |
| Vermont | 6 | 114−10%/yr | −10%/yr | 1.0 | 0% | 50 in 2030−12%/yr |
| 35 |
| 1,875−1.6%/yr |
| −1.6%/yr |
| 1.00.9× |
| 2% |
| 1,980 in 2030+0.9%/yr |
| Kyphoplasty & vertebroplasty | 12 | 1,432−3.1%/yr | −3.1%/yr | 0.80.9× | 29% | 1,740 in 2030+3.3%/yr |
| SI joint fusion | 0 | 175+8.8%/yr | +8.8%/yr | 0.10.7× | 0% | 450 in 2030+17%/yr |
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.
New York’s own discharge file counts every inpatient stay, whatever the payer: 6,540 spinal decompression and discectomy stays at 73 hospitals in 2024, against the Medicare-only figures above. The most commercial of the busy ones is GARNET HEALTH MEDICAL CENTER (50% commercial): where commercial rates leave the most room for a premium product.
| Hospital | Cases | Medicare | Commercial |
|---|---|---|---|
| NEW YORK-PRESBYTERIAN HOSPITAL NEW YORK | 565 | 41% | 38% |
| NYU LANGONE HOSPITALS NEW YORK | 456 | 43% | 32% |
| HOSPITAL FOR SPECIAL SURGERY NEW YORK | 426 | 59% | 34% |
| MOUNT SINAI HOSPITAL NEW YORK | 285 | 52% | 38% |
| KALEIDA HEALTH BUFFALO | 256 | 35% | 28% |
| LENOX HILL HOSPITAL NEW YORK | 251 | 37% | 35% |
| LONG ISLAND JEWISH MEDICAL CENTER NEW HYDE PARK | 198 | 31% | 31% |
| NORTH SHORE UNIVERSITY HOSPITAL MANHASSET | 196 | 37% | 24% |
New York only: MedaRep has no other state’s all-payer file yet. Counted by principal procedure (Spinal decompression and discectomy: only stays where decompression is the main procedure; one done with a fusion counts as the fusion.). Medicare here includes Medicare Advantage. A hospital with 10 or fewer such stays, or a payer share of 10 or fewer, is not shown. Source: New York State Department of Health, SPARCS de-identified inpatient discharges (health.data.ny.gov). The New York State Department of Health makes no representation, warranty or guarantee relating to the data or analyses derived from these data. Accessed 2026-11-11.
Globus Medical leads with 47% of company spending on these surgeons in 2025, +46 pts on 2024.
In 2025, 5 companies reported engagement with New York’s surgeons worth $392K in consulting, speaking, meals and travel tied to these products, about $3,466 per surgeon billing it. Royalties are left out.
FDA, last 12 months: 5 clearances and approvals in the category.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.